🟢 ACHV is trading 6.2% up today after shareholders approve doubling authorized common shares

ACHV is trading at $6.85 (6.2% up) in pre-market after investors approved doubling the company's authorized common shares from 150 million to 300 million at the July 2 annual meeting.

• The move provides future financing flexibility as the company advances its smoking-cessation drug program.
• Market sentiment remains constructive despite potential dilution, as the program has previously driven sharp rallies on positive clinical trial and financing news.